Raymond James Boosts UnitedHealth Group (NYSE:UNH) Price Target to $300.00

UnitedHealth Group (NYSE:UNH) had its price target lifted by research analysts at Raymond James from $265.00 to $300.00 in a note issued to investors on Friday, The Fly reports. The firm currently has a “buy” rating on the healthcare conglomerate’s stock. Raymond James’ price objective points to a potential upside of 16.57% from the company’s previous close.

Several other equities research analysts also recently commented on UNH. Morgan Stanley set a $207.00 target price on Alibaba Group and gave the company a “buy” rating in a report on Friday, July 12th. ValuEngine downgraded Acceleron Pharma from a “strong-buy” rating to a “buy” rating in a research note on Thursday, April 18th. UBS Group set a $36.00 price objective on Halliburton and gave the stock a “buy” rating in a research note on Tuesday, April 23rd. Barclays set a $24.00 price objective on Tenet Healthcare and gave the stock a “hold” rating in a research note on Wednesday, April 17th. Finally, SunTrust Banks reduced their price objective on UnitedHealth Group to $300.00 and set a “buy” rating for the company in a research note on Wednesday, April 17th. They noted that the move was a valuation call. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and seventeen have issued a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $296.56.

Shares of NYSE UNH traded down $3.25 during mid-day trading on Friday, hitting $257.35. 2,781,787 shares of the company traded hands, compared to its average volume of 3,834,000. UnitedHealth Group has a 1 year low of $208.07 and a 1 year high of $287.94. The firm has a market cap of $253.41 billion, a PE ratio of 19.98, a price-to-earnings-growth ratio of 1.43 and a beta of 0.61. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.63. The business’s 50 day moving average is $248.73.



UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, July 18th. The healthcare conglomerate reported $3.60 EPS for the quarter, beating the consensus estimate of $3.46 by $0.14. UnitedHealth Group had a return on equity of 25.07% and a net margin of 5.45%. The business had revenue of $60.60 billion during the quarter, compared to the consensus estimate of $60.59 billion. During the same period in the prior year, the business posted $3.14 earnings per share. UnitedHealth Group’s revenue was up 8.0% compared to the same quarter last year. As a group, equities analysts expect that UnitedHealth Group will post 14.7 EPS for the current fiscal year.

In other news, Director William C. Ballard, Jr. sold 5,000 shares of the firm’s stock in a transaction dated Monday, May 6th. The stock was sold at an average price of $239.02, for a total transaction of $1,195,100.00. Following the completion of the sale, the director now directly owns 77,993 shares of the company’s stock, valued at approximately $18,641,886.86. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO David S. Wichmann purchased 20,000 shares of the business’s stock in a transaction dated Friday, May 3rd. The shares were purchased at an average cost of $231.79 per share, with a total value of $4,635,800.00. Following the completion of the purchase, the chief executive officer now directly owns 904,367 shares in the company, valued at $209,623,226.93. The disclosure for this purchase can be found here. Insiders have sold a total of 35,000 shares of company stock valued at $8,392,500 over the last ninety days. Company insiders own 0.87% of the company’s stock.

Several institutional investors and hedge funds have recently bought and sold shares of UNH. Pearl River Capital LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter valued at about $35,000. Canton Hathaway LLC acquired a new position in shares of UnitedHealth Group during the 1st quarter valued at about $36,000. Laurel Wealth Advisors LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter valued at about $42,000. Truvestments Capital LLC acquired a new position in shares of UnitedHealth Group during the 1st quarter valued at about $42,000. Finally, Creative Financial Designs Inc. ADV increased its holdings in shares of UnitedHealth Group by 89.6% during the 1st quarter. Creative Financial Designs Inc. ADV now owns 201 shares of the healthcare conglomerate’s stock valued at $50,000 after acquiring an additional 95 shares during the last quarter. 85.62% of the stock is owned by institutional investors.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Article: What is the downside to momentum investing?

The Fly

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.